Aging-Driven Reprogramming Of Cd34⁺ Hematopoietic Stem Cells In Leukemogenesis: Mechanisms And Therapeutic Implications
As we age, our bodies undergo many changes, and these changes can sometimes increase our risk for certain diseases, including blood cancers like leukemia. Recent research highlights how the aging process directly impacts the very cells responsible for producing all our blood cells, called hematopoietic stem cells. These particular stem cells, often identified by a marker called CD34, are normally vital for maintaining a healthy blood system throughout our lives.
However, with age, these cells can be “reprogrammed” due to a combination of internal factors, such as damage to their genetic material and changes in how their genes are regulated, and external influences from their surrounding environment in the bone marrow. These alterations can lead to a condition where certain stem cells start to multiply abnormally, a precursor to cancer, and can also weaken our immune system.
Specifically, a subset of these aged stem cells can acquire properties similar to cancer stem cells, becoming resistant to typical treatments. Understanding these age-related changes is crucial because it opens up new avenues for developing therapies that could target the aging mechanisms themselves, or the specific vulnerabilities of these pre-cancerous cells, potentially preventing or better treating blood cancers in older individuals.
Source: link to paper